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Uncoating is an essential step in viral replication cycle. Little is known about the mechanism and requirement of HIVuncoating. Using an in
vitro uncoating model, we demonstrate here that the uncoating of HIV-1 was efficiently induced by lysate from activated CD4+ lymphocytes,
while quiescent CD4+ lymphocyte lysate was unable to uncoat HIV-1 core. The uncoating activity was associated with an induction of in vitro
reverse transcription of the viral genome. Using CD4+ lymphocytes that were arrested in cell cycle, we showed that the uncoating activity
required transition of cells from G0/G1a into G1b stage. These results strongly suggested a requirement of cell cycle-dependent specific factors
for HIV-1 uncoating. The putative HIV-1 uncoating factors could be fractionated from cell lysate by gel filtration chromatography.
D 2005 Elsevier Inc. All rights reserved.Keywords: HIV; Uncoating; Lymphocyte; Resting cell; Cell cycleIntroduction
The events that immediately follow viral penetration into
host cell, but precede transcription or translation of the viral
genome, are commonly referred to as uncoating. The events
require a disassembly of viral capsid in order to release viral
genome. For some naked viruses, such as picornaviruses,
the capsid does not enter target cell but remains on cell
surface while releasing the viral genome through cell
membrane into cytoplasm (Greber et al., 1994; Smyth and
Martin, 2002). This entry/uncoating process of picornavi-
ruses is well characterized and led to development of
antiviral drugs that block the uncoating process (De Clercq,
2002; Florea et al., 2003; Rossmann, 1988). For most other
viruses, the uncoating process is poorly understood. It is
possible that the penetration process itself may trigger the
uncoating process. On the other hand, we have several
examples of viruses that require specific cellular or viral
factors for uncoating. For Sindbis and Semliki Forest
viruses, the cellular uncoating factor was identified to be0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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the uncoating is triggered by pH change in the virion
mediated by an ion channel activity of a viral protein M2
(Sansom et al., 1998). These suggest that the uncoating
process is a tightly regulated process and requires certain
cellular or viral factors.
The major reason for our lack of knowledge in viral
uncoating is the difficulty in studying this process and the
lack of reliable assay. An approach to detect uncoating in
vitro is to measure the disassembly of purified core particles
after incubation with cell lysate. The difficulty of this assay
for HIV is the purification of core particles, which are not
stable in the presence of detergent that is needed to strip
off the envelope. However, a spin-through technique was
described to successfully purify HIV-1 core particles
(Accola et al., 2000). This technique has enabled us to
purify intact core particles of HIV-1 that were further used
for the development of an HIV-1 in vitro uncoating assay.
The principle of the assay is somewhat similar to a
previously described assay that has been used to study
core stability and an association of Nef with the
ribonucleoprotein complex (Forshey and Aiken, 2003;
Forshey et al., 2002).05) 93 – 101
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depend on cellular activation status. In quiescent CD4+ T
cells, the infection is blocked at an early post-entry step. It
was shown that HIV-1 could enter quiescent CD4+ T cells
efficiently, but only short incomplete reverse transcripts were
made (Borvak et al., 1995; Chou et al., 1997; Tang et al.,
1995). The completion of reverse transcription was shown to
require a transition of the cells from G0/G1a into G1b of cell
cycle (Korin and Zack, 1998). These data led to a hypothesis
that some cellular factors that are required for the efficient
reverse transcription or strand transfer may be lacked in
quiescent CD4+ T cells. We, on the other hand, questioned
whether the block was at an earlier step, i.e., the uncoating,
resulting in the inefficiency of the subsequent reverse
transcription step.Results
Purification of HIV-1 core particles and the uncoating assay
Using a previously described spin-through HIV-1
technique for core particle purification with some mod-Fig. 1. A Western blot analysis of a core particle pellet spun through a discontinu
virion pellet purified by ultracentrifugation (lane 2). We detected the bands
immunoglobulin. The arrowheads indicate the positions of the p24 capsid and p17
when examined by an electron microscope after negative staining (b). The dens
centrifugation. Viral supernatant was centrifuged as described for core particle prep
630 (dotted line) that was placed on top of a continuous sucrose density gradien
measured by an ELISA and shown in optical density (OD) (c).ification, we were able to purify core particles without
any contamination of enveloped particles as shown by the
absence of p17 matrix band in Western blot analysis
(Fig. 1a). With electron microscopy, we were able to
show intact core particles with typical size and morphol-
ogy (Fig. 1b). The spin-through techniques yielded
authentic core with typically higher density than virions
that were centrifuged through the same density gradient
without detergent (Fig. 1c).
Since the uncoating process is defined as the disassembly
of viral core intracellularly, we attempted to study this
process in vitro by detecting the disassembly of core
particles in the presence of cellular component. Because
purified core of HIV-1 is unstable in the presence of
detergent, we obtained detergent-free cell lysate by hypo-
tonic and freeze–thaw lysis. Incubation with lysate from
PHA-activated PBMC caused a complete disassembly of the
viral core, while incubation with lysis buffer alone did not.
This indicated that certain cellular factors could cause the
disassembly or uncoating of the viral core (Fig. 2a). To
confirm that the inability to be pellet of the uncoated capsid
protein was genuinely due to the disintegration of core
particles and not the binding of intact core particles toous sucrose gradient with 0.1% Igepal CA-630 (lane 1) comparing with a
with HIV-1 seropositive human serum and HRP-conjugated antihuman
matrix proteins (a). The purified core shows a typical cone-shaped structure
ity of core particles was examined by continuous sucrose density gradient
aration through 10% sucrose with (solid line) and without 0.1% Igepal CA-
t. The levels of p24 antigen in the fractions at a dilution of 1:1000 were
Fig. 2. In vitro uncoating of HIV-1 core by PHA-activated PBMC lysate. The relative uncoating efficiencies are shown in percent of complete disassembly by
detergent. The bars represent uncoating activities in the absence or presence of increasing concentration of cell lysate. The bars represent data from 3 separated
experiments using different donors (a). Fractionation of uncoated p24 capsid protein by FPLC revealed a single peak with expected molecular size of p24
monomer (upper), as determined by the molecular size markers (lower): A, blue dextran (2000 kDa); B, IgG (160 kDa); C, BSA (67 kDa); D,
chymotrypsinogen A (25 kDa); E, lysozyme (14 kDa) (b). A Western blot analysis of core before (lane 2) and after (lane 3) incubation with PHA-activated
PBMC lysate shows no change in the band of p24 capsid protein (c). A representative real-time PCR amplification curve of the reverse transcriptase assay of
supernatants from uncoating reactions showed high levels of RT activity in reactions with cell lysate (2.3  102 unit) and disruption buffer (1.3  102 unit), but
not in negative control reaction with hypotonic lysis buffer (2.7 unit). Reactions with AMV-RT at 104, 102, and 1 unit per reaction for standard curve are also
shown (d).
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of the uncoated capsid protein. We fractionated the
uncoating reaction after fixation in 2% paraformaldehyde.
The p24 capsid protein was found in a single peak in the
fractions close to that of chymotrypsinogen A, which was
used as a molecular size marker and has a molecular weight
of 25 kDa (Fig. 2b). A similar pattern was found when
detergent-treated core was fractionated. This suggested that
majority of the uncoated capsid protein was released from
the viral core as monomer and that the measured uncoating
was in fact the result of disintegration of core particles. We
further questioned whether the in vitro uncoating was
associated with any cleavage of the capsid protein p24. In
a Western blot analysis, p24 band remained unchanged after
incubation with PHA-activated PBMC lysate (Fig. 2c). This
ruled out the possibility that the observed disassembly was
due to non-specific degradation of the capsid protein by a
cellular protease. In order to show the release of the inner
content of the core after disassembly, we measured the RT
activity in the supernatant of the uncoating assay after
ultracentrifugation. Expected amounts of RT activity were
equally found in the reaction with disruption buffer and celllysate, while only background level of activity was detected
in the negative control with hypotonic lysis buffer (Fig. 2d).
The lack of uncoating activity in quiescent CD4+
lymphocytes
Because of the block in HIV replication cycle in
quiescent CD4+ lymphocytes at an early post-entry step,
we questioned whether this might be due to the lack of
uncoating in those cells. To test this hypothesis, we purified
quiescent (CD4+/HLA-DR/CD69/CD25) and acti-
vated (CD4+/HLA-DR+) cells from PBMCs of normal
healthy donors by a fluorescence-activated cell sorter. We
purified quiescent cells from freshly isolated PBMC, but for
activated cells we used PHA-activated PBMC in order to
obtain enough number of fully activated cells. In whole
PBMC, PHA-activation enhanced the uncoating activity
(data not shown). The purity of the cell preparation was
consistently more than 98% and 90% for the quiescent and
activated cell fractions, respectively. There was no contam-
ination of monocyte in the quiescent cell preparation as
demonstrated by the lack of CD14+ cell (Fig. 3a). And these
Fig. 3. PBMCs were stained with anti-CD4, -HLA-DR, -CD69, -CD25, and sorted to purify quiescent CD4+ lymphocyte. Left and right panels show pre-sort
and post-sort flow cytometric dot plots, respectively. Additional to HLA-DR and CD-69, the FL-2 ( y-axis) of post-sort dot plots also shows CD-14 staining (a).
Cell cycle analysis shows DNA content stained with 7AAD in the y-axis and RNA content stained with PY in the x-axis. The dot plots separate cells in G0–G1a
into the left lower quadrant, G1b into the right lower quadrant, and S/G2/M into the right upper quadrant. The analysis showed that the purified quiescent cells
were in G0–G1a (b). In vitro uncoating activities after incubating HIV-1 core with increasing concentration of lysate from activated HLA-DR+/CD4+ T-cells
(solid bars) or with increasing concentration of lysate from quiescent CD4+ T-cells (open bars). The bars represent data from 3 separated experiments using
different donors (c). The in vitro uncoating activity was accompanied by induction of full-length reverse transcription product in the presence of lysate from
activated cells (lane 4) but neither quiescent cells (lane 3) nor in the absence of cell lysate (lane 2). Lane 1 shows 100-base pair DNA ladder molecular size
marker (d).
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infection by HIV-1. In spite of the lower purity of activated
cell population, monocyte did not contribute to the observed
uncoating activity. They were excluded from the sorted
population by their higher SSC, and sorted purified
monocytes had much lower uncoating activity than acti-
vated CD4+ lymphocytes (data not shown). Majority of
contaminating cells in the activated cell population were
quiescent cells. We also demonstrated that the sortedquiescent cells were in G0/G1a by cell cycle analysis (Fig.
3b). Cell lysate from HLA-DR-negative cells did not show
any uncoating activity, while the lysate from HLA-DR-
positive cells induced efficient disassembly of the viral core.
Even with 10 times higher cell concentration, the HLA-DR-
negative cells were unable to induce significant viral core
disassembly (Fig. 3c). The number of activated cells in this
experiment was 10 times lower than that of whole PBMC in
Fig. 2 with similar level of uncoating activity. This
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activated cells from other uncoating-inactive cells. Because
quiescent cells are smaller and may have lower protein
content, we also tested the uncoating activity in activated
and quiescent cells after normalization of protein concen-
tration by a Bradford colorimetric assay and found a similar
level of difference as seen in experiments with cell number
normalization (data not shown). In accordance with the lack
of uncoating activity in quiescent cell lysate, full-length
reverse transcription product could not be induced by the
quiescent cell lysate, while incubation under the same
conditions with activated cell lysate resulted in production
of a full-length reverse transcription product (Fig. 3d).
Uncoating activity and the cell cycle
It has been previously shown that the susceptibility to
HIV-1 infection in CD4+ lymphocytes depended on the
transition of cells from G1a to G1b in the cell cycle. We
therefore asked whether this cell cycle-dependent suscept-
ibility was due to a gaining of the ability to uncoat HIV
core. To obtain CD4+ lymphocytes arrested in G0–G1a and
G1b, we treated freshly prepared PBMCs with n-butyrateFig. 4. The treatment of PHA-activated PBMC with the cell cycle inhibitor n-butyr
sorted CD4+ lymphocytes, while the treatment with Aphidicolin, which accumulate
the cell cycle arrest by the inhibitors. The y-axis shows DNA content stained with
separate cells in G0–G1a into the left lower quadrant, G1b into the right lower qu(5 AM) and aphidicolin (10 mM), respectively, in the
presence of PHA for 3 days. Cell viabilities were deter-
mined by trypan blue dye exclusion and found to be
comparable in control and treated cells. CD4+ cells were
then purified by fluorescence-activated cell sorting from
untreated, aphidicolin-, and n-butyrate-treated cells. While
untreated cells and the G1b arrested (aphidicolin-treated)
cells induced comparable core disassembly, the G0–G1a
arrested (n-butyrate-treated) cells lacked the uncoating
activity (Fig. 4). This result was in agreement with
previously published data and suggested that the cell-
cycle-dependent block in HIV-1 replication cycle was at
least in part due to the lack of uncoating activity in
quiescent G0–G1a cells.
Uncoating factor
Our data suggested the existence of a cellular uncoating
factor. Besides activated CD4+ T cells, the uncoating
activity was also found in various T-cell lines, such as
SupT1 and H9. The fraction containing uncoating activity
could be precipitated with 80% but not 40% ammonium
sulfate (data not shown). We attempted to partially purifyate, which stops the cell cycle at G0–G1a, inhibited the uncoating activity of
d cells at G1b, did not affect the uncoating (a). Cell cycle analysis confirmed
7AAD and the x-axis shows RNA content stained with PY. The dot plots
adrant, and S/G2/M into the right upper quadrant (b).
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uncoating activity mainly in a fraction representing mole-
cular size of approximately 60 kDa. A minor peak of
uncoating activity was also found in a fraction representing
molecular size of approximately 160 kDa (Fig. 5).Discussion
Virus uncoating is one of the least studied processes in
the viral replication cycle. What we learned from a number
of viruses, of which the uncoating processes have been
elucidated, was that the viral uncoating is a multi-step
process triggered by virus–cell interaction. Because we
were able to purify intact core particles, which were quite
stable even in the presence of some detergent, the capsid
disassembly could not be a spontaneous process triggered
only by the lost of contact between capsid and envelope or
matrix. The process therefore needed a specific trigger,
most likely provided by the intracellular environment. ThisFig. 5. Fractionation of H9 cell lysate by FPLC revealed two peaks of
uncoating activity (a). The UV absorbance profile of fractionated molecular
size markers: A, blue dextran (2000 kDa); B, IgG (160 kDa); C, BSA
(67 kDa); D, chymotrypsinogen A (25 kDa); E, lysozyme (14 kDa) (b). The
UV absorbance profile of fractionated H9 lysate (c).putative uncoating factor could theoretically contribute to
some of the unknown aspect of cell tropism. Here we
show that uncoating block could be another factor
responsible for the insusceptibility of quiescent T-cells.
Theoretically, the lack of uncoating activity in quiescent
cells could be due to either a lack of uncoating factor or a
presence of uncoating inhibitor. The uncoating activity in
unsorted PBMC despite the presence of quiescent cells
outnumbering activated cells argues against the presence of
uncoating inhibitor.
We do not know whether uncoating block is the sole
reason for the insusceptibility of quiescent cells. It is quite
possible that factors required in several steps of the
establishment of provirus are absent in quiescent cells.
Although quiescent CD4+ lymphocytes are refractory to
HIV infection in vitro, cells from infected persons are
known to harbor latent proviral DNA (Chun et al., 1997;
Seshamma et al., 1992). These cells are believed to acquire
infection in a stage beyond G0/G1a and then return to
quiescent stage after the establishment of provirus. Recent
studies suggested that a cell does not have to be fully
activated to support HIV infection. T cells without activation
markers could be made susceptible to HIV infection through
the actions of cytokines and the viral protein Nef (Swingler
et al., 2003; Unutmaz et al., 1999). It is likely that these
subtle stimulatory signals are sufficient to activate uncoating
activity in quiescent cells together with specific require-
ments for other steps of the viral replication. Because
infection in permissive resting cells is perhaps more likely to
result in a latent infection, it is important to determine the
difference between refractory and permissive quiescent
cells. This would help us to understand the establishment
and maintenance of viral reservoir.
In accordance to previous reports using similar
approach, our core preparation lacked matrix protein
(Fig. 1a). The matrix protein is a component of preinte-
gration complex. Therefore, it should accompany the core
into cytoplasm. However, the role of the matrix protein is
to transport the preintegration complex into nucleus, and
there is no evidence that the matrix protein is involved in
the uncoating process. Current HIV maturation model also
suggests that there is no direct interaction between core
and matrix in a mature virion (Bukrinskaya, 2004).
Together, these suggest that the uncoating process can be
studied in vitro using purified core without the matrix. On
the other hand, it is also possible that opening of the
matrix coat would also require a specific trigger, which is
not addressed in this study.
Current model of mature HIV-1 capsid composes of
hexameric rings of p24 protein held together by a dimeric
interaction of p24 between adjacent rings (Briggs et al.,
2003; Welker et al., 2000). Previous data showed that the
p24 capsid protein could form dimer but not hexamer in
solution. This suggested that the C-domain to C-domain
dimeric interaction was stable while the N-domain to
N-domain hexameric interaction was not and could only
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C-domain intermolecular interactions (Lanman et al., 2003).
If the dimeric interaction is disrupted, deducing from the
model, it is likely that the hexameric structure would be
destabilized resulting in the release of monomeric p24
protein. Our data showing monomeric p24 capsid protein
from the uncoated core suggested that the C-domain to
C-domain interaction is likely to be the target of the
uncoating process.
Our data have demonstrated the existence of at least
two distinct cellular uncoating factors. These putative
uncoating factors are macromolecules and may have
molecular mass of approximately 60 and 160 kDa. Further
studies to elucidate the nature of the uncoating factors and
the mechanism of uncoating will provide insights to this
yet obscure step in the HIV life cycle. For many viruses,
the uncoating step has been shown to be a successful target
for development of anti-viral drugs, for example, Pleco-
naril for enteroviruses (De Clercq, 2002; Florea et al.,
2003). More understanding in the uncoating of HIV-1 will
hopefully provide us a novel target for anti-viral drug
development.Materials and methods
Purification of HIV-1 core particles
HIV-1 IIIB was harvested from supernatant of infected
SupT1 cells on days 3–5 post-infection when maximum
cytopathic effect was observed. The infected cells were
maintained in RPMI 1640 medium with 10% fetal calf
serum (FCS). The culture medium was changed 24–48 h
before the harvest. Viral core particles were then purified
by a spin-through technique as previously described
(Accola et al., 2000) with some modification. Three
milliliters of cell-free supernatant was overlayered on a
discontinuous sucrose density gradient. The gradient was
composed of 1 ml of 50% sucrose at the bottom and 1 ml
of 10% sucrose containing 0.1% Igepal CA-630 on the
top. The overlayered gradient was then centrifuged at
100,000  g in a SW50.1 rotor (Beckman) for 2 h at 4 -C.
The pellet containing viral core particles was then
resuspended in 5 Al of PBS, pooled, and stored in aliquots
at 80 -C. The core particles were quantitated by
measuring the capsid p24 antigen with an ELISA kit
(Vironostika, Organon Teknika).
For Western blot analysis, virion and core preparations
were mixed with loading buffer, heated in boiling water bath
for 5 min, and loaded onto a 12% polyacrylamide gel. After
a semidry electroblotting, the nitrocellulose membrane was
incubated in Tris-buffered saline (TBS) containing 5% skim
milk and HIV-1-positive serum at dilution 1:100 overnight
at 4 -C, washed 4 times in TBS, incubated in TBS/5% skim
milk containing horseradish peroxidase-conjugated goat
antihuman immunoglobulin (Sigma) for 1 h at roomtemperature, and washed 4 times in TBS. The signal was
then developed by incubating the membrane in TBS with
0.6 mg/ml diaminobenzidine (DAB) and 0.03% hydrogen
peroxide.
Cell sorting and cell lysate preparation
Freshly isolated peripheral blood mononuclear cells
(PBMC) from healthy donors were stained with peritinin
chlorophyll-a-proteins complex (PerCP)-conjugated anti-
CD4, phycoerythrin (PE)-conjugated anti-HLA-DR, PE-
conjugated anti-CD69, and Fluorescein isothiocyanate
(FITC)-conjugated anti-CD25 monoclonal antibodies
(Becton Dickinson). Quiescent CD4+/HLA-DR/
CD69/CD25 lymphocytes were sorted by a fluores-
cence-activated cell sorter (FAC Vantage). The lympho-
cyte population was gated by its low side scatter (SSC)
and the staining profiles. For purification of activated
CD4+ cells, PBMCs were cultured in RPMI 1640 +
10% FCS supplemented with 10 Ag/ml of phytohemag-
glutinin (PHA) for 3 days, stained with anti-CD4 and
anti-HLA-DR antibodies, and CD4+/HLA-DR+ lympho-
cytes were sorted similarly. The sorted cells were
analyzed for purity by flow cytometry with additional
staining of anti-CD14 to monitor the contamination of
monocyte, and by cell cycle analysis as described (Korin
and Zack, 1998). For cell cycle analysis, cells were
resuspended in 0.5 ml of staining buffer (0.15 M NaCl,
0.1 M phosphate-citrate buffer, 5 mM EDTA, 0.5%
bovine serum albumin, 0.03% saponin) with 50 AL of
400 AM 7-amino-actinomycin D (7AAD). After 30-min
incubation at room temperature, the cells were chilled on
ice for 5 min, and 50 AL of 100 AM pyronin Y (PY)
was added. The cells were further incubated on ice for
10 min and then analyzed by flow cytometry. The DNA
and RNA contents were measured using linear scales of
FL3 and FL2, respectively.
Cell lysate was prepared by resuspending washed cell
pellets in hypotonic lysis buffer (10 mM Tris pH 7.4, 1.5
mM MgCl2, 10 mM KCl, 0.5 mM DTT). The cell
suspension was frozen and thawed, incubated on ice for
10 min, and centrifuged at full speed in a refrigerated
microcentrifuge for 5 min. The supernatant was then stored
at 80 -C until used in uncoating assay.
Uncoating assay
Purified core particles (1 ng in 2 Al of PBS) were
incubated with 2 Al of cell lysate at 37 -C for 30 min, then
diluted in 5 ml of PBS and centrifuged at 100,000  g in
a SW50.1 rotor (Beckman) for 2 h at 4 -C. Incubations
with hypotonic lysis buffer and p24 disruption buffer
(Vironostika, Organon Teknika) were done in parallel as
negative and positive controls. The extent of core
disintegration was determined by measuring the level of
p24 in the supernatant after centrifugation. The complete
P. Auewarakul et al. / Virology 337 (2005) 93–101100disruption of core by p24 disruption buffer was considered
100%, and percent disruption by lysates was calculated
accordingly.
Reverse transcriptase activity and endogenous reverse
transcription assay
Reverse transcriptase (RT) activity in the supernatant of
uncoating assay after ultracentrifugation was determined
using an assay modified from a previously described
method (Heneine et al., 1995) by incubating 1 Al of the
supernatant in 10 Al of solution containing 1  RT buffer
(50 mM Tris–HCl, 50 mM KCl, 50 mM MgCl2, 2.5 mM
spermidine, 50 mM DTT), 0.6% NP-40, 0.5 mM dNTP,
10 ng of EMCV (encephalomyocarditis virus) RNA
template, 4 pmol of EMCV primer, and 8 unit of RNase
inhibitor. Avian myeloblastosis virus (AMV)-RT at 104, 102,
and 1 unit per reaction was used to set a standard curve for
quantitation. The reactions were incubated at 42 -C for 1 h
and inactivated at 95 -C for 5 min. The cDNA product was
then measured by a real-time PCR in a SYBR Green dye
detection format.
Endogenous reverse transcription reactions were done in
5-Al volume containing 1 ng of core particles, 1  RT
buffer, 2 mM dNTPs, and 2 Al of cell lysate from sorted
activated or quiescent lymphocytes (2.5  104 cells/Al). The
reactions were incubated at 37 -C for 1 h, then heated in
boiling water bath for 5 min. The full-length reverse-
transcribed products were then detected by PCR using the
primers RU5S (GGCTAACTAGGGAACCCACTG) and
FL-DNA (CAGGTCCCTGTTCGGGCGCC) (Borvak et
al., 1995). The thermal cycle was 28 cycles of 94 -C for
30 s, 42 -C for 30 s, and 72 -C for 30 s.
Fast protein liquid chromatography (FPLC)
Size exclusion chromatography of H9 cell lysate was
done using a Superdex 200 gel filtration column on an
AKTA FPLC system (Pharmacia Biotech). A 200-Al sample
at protein concentration of 5 mg/ml of H9 lysate was
injected, then eluted with phosphate-buffered saline at a
flow rate of 1 ml/min. Absorbance was measured at 214 nm.
Fractions (1 ml) were collected using a Frac-900 fraction
collector (Pharmacia Biotech). Collected fractions were
precipitates with 90% ammonium sulfate, resuspended in
25 Al of PBS, and 10 Al was tested for uncoating activity as
described above. For fractionation of uncoated p24 protein,
an uncoating reaction was fixed in 2% paraformaldehyde,
injected onto a Superdex 75 column, and then eluted with
similar elution conditions.Acknowledgments
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